Mkts

Rapport Therapeutics, Inc.

NASDAQ: RAPP
$25.96-0.11 (-0.42%)
As of Nov 10, 4:00 PM ET

Key statistics

Day range
25.3026.90
52-week range
22.0652.93
Today
Open25.83
Previous close25.96
Volume—
Valuation
Market cap1.55B
P/E ratio—
EPS (TTM)-3.17
Income & risk
Dividend / yield—
Beta1.92
Avg volume640.2K
Discussion

RAPP News

Stories mentioning RAPP from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue20,0000.00
Cost of Goods Sold
Gross Profit0.000.000.000.000.00
Operating Expenses
Research & Development32,71630,25822,27922,68019,57217,19915,54315,689
Sales General & Admin11,4997,536
Total Operating Expenses44,21538,50929,98629,49627,10823,52121,64020,800
Operating Income (Loss)(24,215)(38,509)(29,986)(29,496)(27,108)(23,521)(21,640)(20,800)
Interest Income4,3584,7463,0612,7643,0453,5414,1032,679
Interest Expense
Other Expense
Pretax Income(17,537)(18,121)
Tax Provision
Net Income (Loss)(19,857)(33,763)(26,925)(26,732)(24,063)(19,980)(17,537)(18,121)
Earnings Per Share (Basic)(0.42)(0.87)(0.71)(0.75)(0.68)(0.96)(0.50)(1.70)
Earnings Per Share (Diluted)(0.42)(0.87)(0.71)(0.75)(0.68)(0.96)(0.50)(1.70)
Weighted Average Shares Outstanding (Basic)47,23738,93537,93135,44535,26720,73834,85610,667
Weighted Average Shares Outstanding (Diluted)47,23738,93537,93135,44535,26720,73834,85610,667

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About RAPP

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is a stock listed on the Nasdaq Stock Market under the ticker symbol RAPP. It last traded at $25.96 (Nov 10, 2026, 4:00 PM ET), down 0.4% on the day. That gives Rapport Therapeutics a market capitalisation of $1.5B.

Over the past 52 weeks RAPP has traded between $22.06 and $52.93.

Revenue for the quarter ended Mar 31, 2026 was $20.0M; a net loss of $19.9M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$20.0M-$19.9M-99.3%
Dec 31, 2025—-$33.8M—
Sep 30, 2025—-$26.9M—
Jun 30, 2025—-$26.7M—

From Rapport Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…